Public company info - TOT BIOPHARM International Company Limited , 01875.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

TOT BIOPHARM International Company Limited, 01875.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities 57,664 -176,106 -263,202 -250,805 -175,107 -117,590
Net Cash Flow from Return on Investments & Servicing of Finance -4,122 -1,031 86 -524 -1,725 202
 Interest Received 2,265 969 1,880 1,680 727 431
 Interest Paid -6,387 -2,000 -1,794 -2,204 -2,452 -229
 Dividend Received 0 0 0 0 0 0
 Dividend Paid 0 0 0 0 0 0
 Others 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0
Net Cash Flow from Investing Activities -282,764 -108,393 12,526 -51,102 -47,067 -110,957
 Additions to Fixed Assets -238,980 -112,283 -20,487 -36,286 -69,604 -111,908
 Disposal of Fixed Assets 1,875 18 358 19 0 0
 Increase in Investments -260,150 -1,500 -365,570 -131,800 -116,500 -60,300
 Decrease in Investments 215,634 8,402 399,919 118,019 147,631 84,026
 Net Cash Flow with Related Parties 409,164 0 0 0 0 0
 Others -410,307 -3,030 -1,694 -1,054 -8,594 -22,775
Net Cash Flow before Financing Activities -229,222 -285,530 -250,590 -302,431 -223,899 -228,345
Net Cash Flow from Financing Activities 487,627 214,082 -61,707 583,022 457,601 235,179
 New Loans 277,858 205,966 0 60,000 38,693 30,000
 Loans Repayment -198,200 -1,494 -61,707 -2,083 -68,967 -1,333
 Fixed Income/Debt Instruments 0 0 0 0 489,321 206,512
 Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0
 Equity Financing 0 1,990 0 525,105 0 0
 Net Cash Flow with Related Parties 409,164 0 0 0 0 0
 Others -1,195 7,620 0 0 -1,446 0
Increase(Decrease) in Cash & Cash Equivalents 258,405 -71,448 -312,297 280,591 233,702 6,834
Cash & Cash Equivalents at Beginning of Year 152,805 225,533 539,180 256,751 24,581 20,044
Net Cash Flow due to Change in Exchange Rate/Others 6,559 -1,280 -1,350 1,838 -1,532 -2,297
Cash & Cash Equivalents at End of Year 417,769 152,805 225,533 539,180 256,751 24,581
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2025
Suntek Computer Systems Limited.
All rights reserved